prrsv
live
vaccin
wide
use
pig
farm
practic
usual
adjuv
safeti
issu
would
use
reduc
antigen
load
vaccin
preserv
efficaci
studi
show
addit
polym
oil
adjuv
prr
live
vaccin
enhanc
protect
challeng
vaccin
anim
compar
nonadjuv
commerci
refer
moreov
type
adjuv
despit
lower
antibodi
titer
protect
challeng
given
adjuv
vaccin
contain
antigen
load
equival
protect
given
nonadjuv
vaccin
result
demonstr
addit
relev
adjuv
enhanc
efficaci
protect
confer
anim
live
vaccin
live
vaccin
base
infecti
properti
attenu
genet
modifi
live
pathogen
gener
use
vaccin
young
anim
wide
employ
veterinari
practic
develop
larg
spectrum
speci
pig
poultri
companion
anim
hors
pet
live
vaccin
exist
bacteri
viral
parasit
pathogen
model
case
live
vaccin
contain
adjuv
invivo
pathogen
multipl
infecti
properti
attenu
modifi
pathogen
estim
suffici
induc
protect
immun
respons
howev
benefit
anticip
use
adjuv
live
vaccin
concern
safeti
efficaci
improv
import
would
reduct
antigen
dose
deliv
would
lead
safeti
improv
cost
limit
better
control
risk
link
vaccin
procedur
inde
wherea
experiment
condit
efficaci
demonstr
use
nonadjuv
live
vaccin
vaccin
anim
still
present
lack
protect
field
practic
live
vaccin
deliveri
use
adjuv
reduc
number
low
respond
anim
therefor
reduc
possibl
reservoir
diseas
reduc
antigen
load
could
also
lower
risk
revers
live
vaccin
inde
also
impact
econom
perform
herd
revers
virul
alreadi
observ
field
final
wherea
cost
bacteri
viral
vaccin
product
low
vaccin
strain
parasit
pathogen
expens
maintain
produc
model
adjuv
molecul
shown
increas
efficaci
live
vaccin
exampl
chitosan
iscom
howev
laboratori
adjuv
hardli
compat
industrialscal
product
contrari
rang
adjuv
well
establish
brand
vaccin
adjuv
alreadi
use
farm
anim
model
industri
scale
combin
divers
type
antigen
studi
assess
efficaci
safeti
montanid
tm
adjuv
live
prr
vaccin
pig
porcin
reproductori
respiratori
syndrom
prr
one
econom
import
diseas
pig
farm
prr
pathogen
simpl
rna
strand
arteriviru
caus
reproduct
failur
sow
respiratori
syndrom
pig
age
live
prr
vaccin
wide
use
pig
practic
two
differ
adjuv
technolog
test
studi
formul
aqueou
continu
phase
vaccin
gel
st
gel
polym
base
adjuv
isa
vg
isa
oil
adjuv
allow
formul
oilinwat
emuls
adjuv
use
extemporan
diluent
lyophil
prr
antigen
studi
show
gel
isa
adjuv
formul
significantli
improv
protect
confer
pig
use
antigen
dose
use
commerci
vaccin
show
adjuv
technolog
also
allow
reduct
antigen
load
prr
vaccin
ten
landrac
cross
larg
white
commerci
pig
kg
use
experiment
group
clinic
healthi
free
prr
classic
swine
fever
csf
swine
influenza
aujeszki
diseas
transmiss
gastroenter
swine
tge
mycoplasma
hyopneumonia
actinobacillu
pleuropneumonia
protocol
valid
intern
arriah
ethic
comiti
prior
launch
accord
oie
recommend
passag
cell
cultur
ingelvac
respprr
mlv
vaccin
strain
prr
viru
north
american
genotyp
freezedri
use
protect
medium
fgi
arriah
consist
saccharos
lactalbumin
hydrolyz
gelatos
prr
viru
titer
one
vaccin
dose
ml
amount
log
isa
vg
isa
gel
st
gel
use
studi
isa
readi
use
rang
oil
adjuv
use
manufactur
differ
type
emuls
isa
allow
formul
oilinwat
vaccin
gel
st
readi
dilut
polymer
adjuv
contain
gel
particl
sodium
polyacryl
water
absenc
viricid
effect
gel
isa
adjuv
assess
vitro
prior
vaccin
safeti
efficaci
studi
studi
perform
accord
usp
method
adjuv
formul
extemporari
vaccin
mix
antigen
phase
analogu
live
commerci
prr
vaccin
prepar
posit
refer
nonadjuv
live
prr
vaccin
prepar
dilut
freezedri
antigen
salin
solut
use
posit
control
vaccin
contain
adjuv
pig
randomli
separ
group
anim
group
group
anim
group
non
vaccin
non
challeng
group
anim
vaccin
intramuscular
deliveri
correspond
group
test
vaccin
anim
receiv
ml
vaccin
anim
group
pig
left
unvaccin
trial
anim
behavior
follow
vaccin
deliveri
order
identifi
modif
relat
vaccin
procedur
rectal
temperatur
measur
post
vaccin
local
reaction
vaccin
assess
dissect
inject
site
slaughter
blood
sampl
collect
pig
vaccin
day
day
post
vaccin
antigen
specif
antibodi
detect
individu
date
antigen
specif
elisa
enzym
link
immunosorb
assay
elisa
procedur
perform
accord
manufactur
protocol
prr
antibodi
detect
kit
idexx
elisa
westbrook
usa
infecti
challeng
procedur
perform
day
post
vaccin
intranas
infect
highli
virul
irkutski
isol
north
american
genotyp
passag
titer
log
infect
anim
clinic
observ
daili
observ
includ
temperatur
measur
registr
clinic
sign
pig
sera
analys
pcr
presenc
prr
viru
challeng
day
post
challeng
pig
slaughter
week
post
challeng
sampl
lung
lymph
node
collect
postmortem
examin
degre
lung
lesion
determin
use
method
halbur
et
al
lung
damag
directli
link
viru
activ
bacteri
infect
occur
local
immun
suppress
due
prrsv
lung
lesion
score
use
previous
develop
system
base
approxim
volum
lobe
contribut
entir
lung
right
cranial
lobe
right
middl
lobe
cranial
part
left
cranial
lobe
caudal
part
left
cranial
lobe
contribut
total
lung
volum
accessori
lobe
contribut
right
left
caudal
lobe
contribut
score
use
calcul
total
lung
lesion
score
base
rel
contribut
lobe
statist
analysi
perform
use
anova
analysi
result
consid
significantli
differ
signif
viricid
effect
could
observ
prr
live
vaccin
either
montanid
gel
pr
montanid
isa
vg
gel
isa
decreas
viru
titer
respect
log
log
modif
anim
behavior
social
movement
feed
could
observ
vaccin
deliveri
protocol
administr
isa
gel
adjuv
vaccin
bodi
temperatur
rise
tabl
pyrogen
effect
significantli
differ
adjuv
vaccin
nonadjuv
vaccin
group
inject
site
dissect
show
vaccin
relat
side
effect
antibodi
titer
measur
post
inject
kinet
antibodi
respons
modifi
accord
antigen
load
presenc
adjuv
figur
base
group
commerci
vaccin
control
present
seroconvers
day
vaccin
anova
analysi
demonstr
signific
differ
could
observ
adjuv
group
contain
antigen
load
refer
nonadjuv
group
howev
vaccin
contain
antigen
induc
lower
antibodi
level
compar
commerci
refer
infecti
prr
challeng
procedur
perform
day
vaccin
one
anim
nonvaccin
group
die
challeng
anim
death
observ
vaccin
group
bodi
temperatur
measur
challeng
tabl
vaccin
group
show
significantli
reduc
durat
hyperthermia
compar
nonvaccin
control
durat
hyperthermia
also
significantli
reduc
isa
adjuv
group
antigen
dose
compar
commerci
vaccin
group
vaccin
contain
contain
gel
antigen
dose
formul
contain
antigen
load
durat
hyperthermia
significantli
differ
commerci
vaccin
contain
antigen
load
number
virem
pig
defin
pcr
analysi
sera
day
challeng
shown
figur
signific
differ
could
observ
vaccin
group
slaughter
lung
lesion
score
measur
figur
pneumonia
observ
challeng
variabl
pig
pig
despit
variabl
pig
vaccin
gel
isa
adjuv
vaccin
contain
antigen
load
show
significantli
less
lung
damag
nonvaccin
control
group
none
vaccin
group
induc
signific
protect
compar
nonvaccin
control
moreov
lower
lesion
score
observ
adjuv
formul
contain
antigen
dose
compar
nonadjuv
commerci
vaccin
formula
due
high
variabl
measur
differ
signific
studi
shown
use
adapt
adjuv
improv
efficaci
live
prr
vaccin
pig
preserv
safeti
properti
local
reaction
low
pyrogen
crucial
inform
collect
select
adjuv
live
vaccin
model
compat
adjuv
live
vaccin
viricid
effect
could
observ
prr
live
vaccin
either
montanid
gel
pr
montanid
isa
vg
howev
pathogen
product
attenu
complex
mechan
antigen
media
uniqu
process
thu
compat
studi
perform
new
antigen
phase
field
trial
order
valid
result
main
target
adjuv
addit
live
vaccin
increas
efficaci
vaccin
reduct
antigen
load
per
dose
order
reduc
cost
reduc
risk
revers
increas
product
capac
could
show
adjuv
vaccin
contain
antigen
dose
unadjuv
commerci
vaccin
could
significantli
improv
resist
challeng
length
hyperthermia
lung
lesion
despit
similar
antibodi
titer
compar
commerci
nonadjuv
refer
lung
lesion
good
indic
vaccin
perform
strongli
link
bodi
weight
gain
anim
also
note
challeng
highli
discrimin
vaccin
experiment
well
commerci
inde
virul
strain
viru
use
present
genet
homolog
chines
strain
induc
mortal
field
condit
vaccin
contain
antigen
dose
induc
lower
antibodi
titer
commerci
refer
level
protect
challeng
significantli
differ
commerci
vaccin
differ
protect
challeng
antibodi
titer
could
link
cellular
modal
immun
respons
also
involv
respons
prr
first
result
show
use
polym
ow
emuls
adjuv
could
improv
protect
prr
vaccin
anim
allow
reduct
antigen
load
live
prr
vaccin
confirm
larg
scale
field
trial
need
confirm
result
work
underlin
abil
use
montanid
tm
polym
emuls
adjuv
live
vaccin
prr
open
door
improv
live
swine
vaccin
safeti
efficaci
